Sandyford home of Grafton Group and Cubic Telecom seeking €24.2m
Sandyford Business District
in south Dublin.
The property –
which was first put up for sale on behalf of Spectre, a joint venture involving U+I and US investor Colony Capital, for €34.4 million in 2022
– is being offered to the market now for €24.2 million.
The Hive, which was known formerly as Ballymoss House, underwent a comprehensive refurbishment in 2019. The building comprises 6,785sq m (73,000sq ft) of grade A office space distributed over four floors, and comes with LEED Gold certification, an A3 Ber rating, and the highest WiredScore and CycleScore ratings.
Located 500 metres from the Luas Green line stop at Sandyford and within a short drive of both the M50 motorway and the N11, the property also includes 114 car parking spaces, 96 cycle spaces and 12 EV charging stations.
READ MORE
The Hive is generating annual rental income of €1.95 million, with a weighted average unexpired lease term (WAULT) of 8.2 years to expiry, underpinned by a strong tenant line-up, which includes the global connectivity software specialist Cubic Telecom, the FTSE-listed Grafton Group, and the infrastructure investor and asset manager NTR plc. Should a sale of the property proceed at the guide price, the new owner would be in line for a net initial yield of about 7 per cent.
[
French investor pays €47.2m for Smithfield office block
Opens in new window
]
Iain Sayer of HWBC says: 'The Hive is a prime example of the type of office investment attracting European capital today – long, secure income, blue-chip tenants, and best-in-class sustainability specifications. With strong occupier demand in Sandyford and an attractive yield profile, we expect interest from a wide range of investors.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
an hour ago
- Irish Times
Novo Nordisk freezes hiring in push to rein in costs
Novo Nordisk is to freeze hiring in an effort to control costs at the drug maker. The halt will apply across all markets and departments, with the exception of business-critical roles, a company spokeswoman said on Wednesday. Novo's new chief executive officer, Maziar Mike Doustdar, has signaled that job cuts may be part of a promised revamp, telling reporters last month that Novo needs to exercise greater discipline and prudence on spending. He said he plans to review the company's cost base. The maker of Wegovy and Ozempic, which employs close to 500 people in Ireland, is fighting to claw back ground after losing its lead in the US obesity market to rival Eli Lilly & Co. Lilly's weight-loss franchise is poised to overtake Novo's this year and may hold more than half of a $100 billion global obesity market by 2030, Bloomberg Intelligence analyst Michael Shah said. Novo ousted its longtime CEO in the second quarter as the foundation that controls the company pushed for an overhaul, and Doustdar took over earlier this month. Novo's workforce mushroomed to more than 78,000 people in recent years as the drugmaker rushed to boost production of its blockbusters Ozempic and Wegovy. On Wednesday, the company's website had just over 400 jobs posted globally, most of them in China and the U.S. Only eight positions were open in its home market of Denmark. --Bloomberg
Irish Examiner
an hour ago
- Irish Examiner
Kenmare urges decision on Mozambique rights renewal
Titanium miner Kenmare Resources said on Wednesday it could seek arbitration over delays to an extension of its mining rights in Mozambique. The Dublin-headquartered company owns the Moma Titanium Minerals mine on the north-east coast of Mozambique, mainly producing ilmenite. The mineral is a source of titanium dioxide used mainly in industrial paints and coatings as well as in electronic equipment, packaging, pharmaceuticals and cosmetics. Kenmare said it has been in inconclusive talks with the Mozambican authorities since 2022 to renew a 20-year mining and export agreement that lapsed in December 2024. "We are concerned at the continued extension of this process," Kenmare managing director Tom Hickey said in a statement. "While we remain hopeful of a successful conclusion to negotiations, we reserve the right to safeguard Kenmare's contractual entitlements, up to and including arbitration, if an agreement cannot be reached," he added. Hickey told Reuters in an interview that the royalty rate was a major hurdle in agreeing new terms. "We've been told, when this agreement went to the Council of Ministers back in March, the royalty was the principal sticking point," Hickey said. "We have made a proposal that we hope will be seen as satisfactory to address that, but we just want a conclusion," he added. The Mozambican government was not immediately available to comment. Kenmare's proposals include a phased increase in the royalty rate from 2.5% in 2025 to 3.5% over the course of the 20-year agreement, a withholding tax on payments to non-Mozambican suppliers as well as further capital investments and contributions to community development projects. On Wednesday, Kenmare reported $160 million of mineral sales in the six months to June 30, a 3% increase on the same period last year. Weak prices in an oversupplied market slashed its half-year profit by 71% to $6.1 million. Reuters
Irish Times
2 hours ago
- Irish Times
Irish house price inflation at 7.8% in June amid ongoing supply shortage
House prices in the Republic grew at an average annual rate of 7.8 per cent in June, keeping the pressure on would-be buyers. The headline rate was unchanged from the previous month and down from over 10 per cent last year. The Central Statistics Office's (CSO) latest barometer indicated prices in Dublin, where supply pressures are strongest, rose at an annual rate of 6.6 per cent in June while prices outside the capital were up by 8.8 per cent year-on-year. The median or middle price paid for a home in the 12 months to June was €370,000. READ MORE
